Home » Newsletters » BioWorld

BioWorld

Oct. 19, 1992

View Archived Issues

GENELABS GRANTS CO-MARKETING RIGHTS

AMGEN NAMES PRESIDENT

EUROPEAN PATENT DISCLOSURES

EUROPEAN LOBBY GROUP NIXES BIODIVERSITY

MOUSE MUTANT TO TAKE ON ATHEROSCLEROSIS

ENZON GETS RIGHTS TO GAUCHER'S DRUG

BIOCRYST FILES ANOTHER IND FOR BCX-34

USDA DEREGULATES CALGENE TOMATO

ALPHA-BETA RETURNS TO IPO MARKET FOR $16M

APPLIED IMMUNE MOVES TO LARGER FACILITY